Venus Medtech Hangzhou. has filed a patent for an intra-vascular device designed to filter or deflect emboli from entering secondary vessels. The device includes a filter, lateral structure, wires for control, and detachable components for easy installation in blood vessels. GlobalData’s report on Venus Medtech Hangzhou gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Venus Medtech Hangzhou Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Venus Medtech Hangzhou, Prosthetic cardiac valves was a key innovation area identified from patents. Venus Medtech Hangzhou's grant share as of January 2024 was 47%. Grant share is based on the ratio of number of grants to total number of patents.

Intra-vascular device for filtering or deflecting emboli

Source: United States Patent and Trademark Office (USPTO). Credit: Venus Medtech Hangzhou Inc

The patent application (Publication Number: US20230414336A1) describes a device designed to deflect emboli, consisting of a filter with a lateral structure, a hollow tube, and wires for controlling the device's position. The device includes features such as a screw-like mechanism, radiopaque markers, and the ability to form a seal in the aortic arch. Made from metal wire, the device is compact and includes components for easy deployment and retrieval.

Furthermore, the patent application details a system incorporating the device loaded into a catheter, complete with a guide wire and protective features like a dilator and a protected lip. The system allows for controlled expansion of the device within the blood vessel, with additional components like a pigtail catheter for enhanced functionality. A method for introducing the system into a subject involves inserting the device into a blood vessel and deploying it by retracting the catheter, utilizing the first and second wires for precise positioning within the aortic arch. Overall, the patent application outlines a comprehensive solution for deflecting emboli with a focus on ease of use and effectiveness in medical procedures.

To know more about GlobalData’s detailed insights on Venus Medtech Hangzhou, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies